Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease Jan. 17, 2022
Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes Jan. 7, 2022
RSS